Trial Profile
Clinical Trial of RK-01 (Celecoxib/metformin/valsartan) RK-01 in healthy, adult volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Celecoxib/metformin/valsartan (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Proof of concept
- 10 May 2018 New trial record
- 11 Apr 2018 According to an ARKAY Therapeutics media release, the company has filed an IND with the U.S. FDA for RK-01.